Önemli: Bu içerik kişisel tıbbi değerlendirme ve muayenenin yerine geçmez. Acil durumlarda önce doktor veya acil servise başvurun — 112.
Diseases & Conditions
Ovarian Hyperstimulation Syndrome
A reliable guide to ovarian hyperstimulation syndrome, including symptoms, risk factors, monitoring, and treatment approach.
Ovarian hyperstimulation syndrome, often abbreviated OHSS, is a complication that can develop after ovarian stimulation used in fertility treatment. It occurs when the ovaries respond excessively to medication, leading to ovarian enlargement and fluid shifts within the body. Many cases are mild, but moderate and severe forms can require close monitoring or hospital care. For that reason, symptoms after stimulation should be interpreted carefully rather than dismissed as routine bloating. [1][2][4]
How does OHSS develop?
OHSS typically develops when the ovaries are stimulated to produce multiple follicles and then respond excessively, particularly around the time of ovulation triggering. Increased vascular permeability allows fluid to move from the bloodstream into the abdomen and, in more severe cases, other body compartments. This is why patients may develop abdominal bloating, rapid weight gain, discomfort, and reduced urine output rather than simply ovarian pain alone. [1][2][5]
The syndrome is most often associated with fertility treatment, especially IVF-related stimulation. Although ovarian enlargement is expected to some extent during treatment, OHSS goes beyond a normal response. It reflects an exaggerated physiological reaction that may vary from mild transient symptoms to clinically significant fluid imbalance and thrombotic risk. Recognizing that difference is important for both patients and care teams. [1][4][6]
What are the symptoms?
Symptoms may include abdominal bloating, pelvic discomfort, nausea, vomiting, diarrhea, rapid weight gain over a short period, and a feeling of abdominal fullness. In more severe cases, shortness of breath, markedly reduced urination, severe abdominal pain, dizziness, or chest symptoms may occur. The key issue is not only which symptoms are present, but also how quickly they are changing. [2][4][5]
Mild symptoms can resemble expected treatment effects, which is why timing and progression matter. If abdominal distension worsens quickly, fluid intake becomes difficult, or breathing feels more labored, urgent reassessment may be needed. Severe OHSS may affect circulation, kidney function, and clotting risk, so progressive symptoms should not be monitored passively without clinical input. [1][2][6]
Who is at higher risk?
Risk is generally higher in people with polycystic ovary syndrome, high ovarian reserve, a large number of developing follicles, younger age in some treatment settings, high estradiol responses, or a prior history of OHSS. Pregnancy after the stimulation cycle may prolong or worsen the course in some patients because endogenous hormonal changes can sustain the syndrome. [1][3][7]
Not every IVF patient develops OHSS. Risk depends on the stimulation protocol, the ovarian response, and individual biological features. This is why many fertility programs use preventive strategies such as protocol adjustments, trigger modifications, freezing all embryos in selected cases, or closer follow-up when risk markers are present. Prevention planning is part of modern fertility care rather than an afterthought. [1][3][8]
How are diagnosis and follow-up performed?
Diagnosis is based on symptoms, examination findings, the recent fertility-treatment history, and, when necessary, laboratory testing and imaging. Clinicians may monitor weight, abdominal circumference, fluid balance, urine output, blood counts, kidney function, and ultrasound findings. The aim is to determine severity, identify dehydration or hemoconcentration, and decide whether outpatient monitoring is sufficient or hospital assessment is required. [1][2][5]
Follow-up is especially important because severity may change over a short period. A patient who initially appears mildly affected may worsen over the next 24 to 48 hours. This is one reason fertility teams often provide clear instructions about weight tracking, warning signs, and when to call. Good monitoring is not alarmism; it is a practical way to catch complications early. [1][4][6]
How is it treated?
Treatment depends on severity. Mild cases are often managed with close outpatient follow-up, symptom monitoring, hydration guidance, and activity recommendations tailored by the treating team. Moderate or severe cases may require more intensive assessment, intravenous fluids, pain control, laboratory monitoring, and sometimes hospital admission. Because the syndrome involves fluid shifts rather than simple dehydration alone, management should be individualized rather than improvised at home. [1][2][5]
In severe cases, clinicians also pay attention to respiratory symptoms, clotting risk, kidney function, and the possibility of large fluid collections. The goals are to stabilize the patient, prevent complications, and support recovery while the hormonal stimulation effect subsides. Self-directed treatment without fertility-team guidance is not appropriate when symptoms are escalating. [1][4][6]
When should someone contact a doctor?
Medical advice should be sought promptly if abdominal swelling becomes marked, weight rises rapidly, urine output drops, vomiting becomes persistent, oral intake becomes difficult, or shortness of breath appears. Chest pain, severe dizziness, inability to keep fluids down, or worsening breathing should be treated as urgent. [2][4][6]
Patients often ask whether “just resting at home” is enough. Rest may be part of the plan in mild cases, but it is not a substitute for appropriate monitoring. Because OHSS can evolve, the safest approach is to follow the fertility clinic’s instructions closely and report changes early instead of waiting for severe symptoms to become unmistakable. [1][5][8]
Persistent, worsening, or function-limiting symptoms require individualized medical evaluation; this content does not replace a diagnosis. [1]
FAQ
Does OHSS occur in every IVF patient?
No. Many patients do not develop OHSS. Risk depends on the stimulation response, the treatment protocol, and individual factors such as ovarian reserve or PCOS. [1][3]
If pregnancy occurs, can OHSS last longer?
Yes. In some patients, pregnancy can prolong or intensify the syndrome because hormonal stimulation continues. [1][2]
When is abdominal bloating dangerous?
It becomes more concerning when it worsens quickly, is associated with rapid weight gain, reduced urination, severe pain, vomiting, or shortness of breath. [2][4][6]
Can OHSS be prevented?
Risk cannot always be eliminated completely, but it can often be reduced through protocol adjustments, careful monitoring, and preventive strategies in high-risk patients. [1][3][7]
Is resting at home enough on its own?
Not necessarily. Mild cases may be monitored as outpatients, but home rest alone is not a replacement for proper medical follow-up when symptoms are progressing. [1][5]
References
- 1.American Society for Reproductive Medicine. Prevention and treatment of moderate and severe ovarian hyperstimulation syndrome: a guideline. 2023. https://www.asrm.org/practice-guidance/practice-committee-documents/prevention-and-treatment-of-moderate-and-severe-ovarian-hyperstimulation-syndrome-a-guideline/
- 2.MedlinePlus. Ovarian hyperstimulation syndrome. 2025. https://medlineplus.gov/ency/article/007294.htm
- 3.ASRM Practice Guidance. Prevention of moderate and severe ovarian hyperstimulation syndrome: a guideline (2023). https://integration.asrm.org/practice-guidance/
- 4.Mayo Clinic. Ovarian hyperstimulation syndrome - Symptoms & causes. https://www.mayoclinic.org/diseases-conditions/ovarian-hyperstimulation-syndrome-ohss/symptoms-causes/syc-20354697
- 5.Mayo Clinic. Ovarian hyperstimulation syndrome - Diagnosis & treatment. https://www.mayoclinic.org/diseases-conditions/ovarian-hyperstimulation-syndrome-ohss/diagnosis-treatment/drc-20354703
- 6.NHS Sussex. Ovarian Hyperstimulation Syndrome (OHSS). 2022. https://www.uhsussex.nhs.uk/resources/ovarian-hyperstimulation-syndrome-ohss/
- 7.ASRM. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. 2023. https://www.asrm.org/practice-guidance/practice-committee-documents/recommendations-from-the-2023-international-evidence-based-guideline-for-the-assessment-and-management-of-polycystic-ovary-syndrome/
- 8.Mayo Clinic. Female infertility - Diagnosis & treatment. https://www.mayoclinic.org/diseases-conditions/female-infertility/diagnosis-treatment/drc-20354313
